Biocytogen Pharmaceuticals (Beijing) Co., Ltd.: Biocytogen Expands Partnership with Merck

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") entered into a global licensing agreement with Merck for the use of Biocytogen's RenMice platform. Under the terms of the agreement, Merck

Related Keywords

Germany , Beijing , China , Boston , Massachusetts , United States , Heidelberg , Baden Wüberg , Shanghai , Canada , Haimen Jiangsu , Yuelei Shen , Biocytogen Renmice , Li Hui , Serono , Biocytogen Pharmaceuticals Beijing Co Ltd , Biocytogen Pharmaceuticals , Biocytogen , Pharmaceuticals , Xpands , Partnership , Merck ,